Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-02-06 | LUMOS PHARMA, INC. | McKew John C.
(Chief Scientific Officer) |
S | Common Stock | D | 438 | $3.03 - $3.03 | $1,328 |
| 2024-02-01 | LUMOS PHARMA, INC. | McKew John C.
(Chief Scientific Officer) |
F | Common Stock | D | 366 | $3.01 - $3.01 | $1,101 |
| 2024-02-01 | LUMOS PHARMA, INC. | Hawkins Richard J
(Chief Executive Officer) |
F | Common Stock | D | 690 | $3.01 - $3.01 | $2,076 |
| 2024-02-01 | LUMOS PHARMA, INC. | Lawley Lori D
(Chief Financial Officer) |
F | Common Stock | D | 215 | $3.01 - $3.01 | $647 |
| 2024-02-01 | LUMOS PHARMA, INC. | Schuchart Aaron
(Chief Business Officer) |
F | Common Stock | D | 202 | $3.01 - $3.01 | $608 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |